Shang‐Jen Chang

About

Dr. Shang-Jen Chang is a leading figure in minimally invasive gynecologic and urologic surgery, with a focused expertise in the surgical management of pelvic organ prolapse and pediatric urology. His major contributions lie in rigorously comparing the outcomes of robotic-assisted, laparoscopic, and open surgical techniques. Through his highly cited work—including a 2021 study on sacrocolpopexy (45 citations) and a 2015 meta-analysis on pediatric pyeloplasty (39 citations)—Dr. Chang has provided crucial evidence on the efficacy, safety, and comparative effectiveness of robotic surgery. His 2021 network meta-analysis (22 citations) further synthesizes global data, offering a comprehensive hierarchy of surgical approaches for pelvic organ prolapse. By systematically evaluating these advanced techniques, Dr. Chang’s research directly informs clinical decision-making, helping surgeons and patients weigh the benefits of robotic assistance against traditional methods. His work has significantly shaped modern surgical protocols, demonstrating a commitment to evidence-based practice and improved patient outcomes in complex pelvic floor and pediatric reconstructive surgery.

Research Focus

Key Achievements

Top Papers

1. 1
   Comparing the outcomes and effectiveness of robotic-assisted sacrocolpopexy and laparoscopic sacrocolpopexy in the treatment of pelvic organ prolapse

   45 citations · 2021
2. 2
   Comparing the efficacy and safety between robotic-assisted versus open pyeloplasty in children: a systemic review and meta-analysis

   39 citations · 2015
3. 3
   An updated systematic review and network meta-analysis comparing open, laparoscopic and robotic-assisted sacrocolpopexy for managing pelvic organ prolapse

   22 citations · 2021

Key Collaborators

Contact & Links